US Value, Evidence and Outcomes
GlaxoSmithKline
Chris Bell, is a member of the US Value Evidence and Outcomes (US VEO) team at GSK in Durham, North Carolina. Mr. Bell has 25+ years of experience in the pharmaceutical and healthcare consulting industries. In his current role, Mr. Bell leads the US evidence generation strategy for GSK's specialty pipeline, collaborating with colleagues in allied functions including health outcomes, real world data analytics and epidemiology, medical affairs, market access and commercial to ensure the right evidence is available at the right time for population-based decision-makers in the US.